Brisbane scientist awarded for research into new blood cancer treatments
Clinical haematologist Associate Professor Steven Lane wants to lift the survival rates of his leukaemia patients. He thinks the key could lie in the genetic fingerprints of the blood cancer stem cells that proliferate the disease.
Steven is studying how these cells become resistant to treatment through genetic changes. He will use the knowledge to develop more effective and tailored therapies, both to prevent and treat potentially fatal relapses.
In recognition of his leadership in stem cell research, he has received one of two annual $55,000 Metcalf Prizes from the National Stem Cell Foundation of Australia.
[Read more…] about Genes may hold key to leukaemia survival